1. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology. 2004; 40:6–9.
Article
2. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clin Toxicol (Phila). 2012; 50:911–1164.
Article
3. Kim HJ, Kim YW, Kim H, Park CB, So BH, Lee KR, Lee KW, Lee KW, Lee SW, Lee JY, Cho GC, Cho J, Chung SP. Comparison between emergency patient poisoning cases and the Tox-Info System Database. J Korean Soc Clin Toxicol. 2012; 10:8–14.
4. Kim J. Tylenol syrups for children recalled. The Korea Times. 2013. 04. 23.
6. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973; 187:211–217.
7. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977; 2:432–434.
Article
8. Chung SP, Kim SH, Lee HS. Acetaminophen poisoning. J Korean Soc Clin Toxicol. 2008; 6:1–8.
9. McGilveray IJ, Mattok GL, Fooks JR, Jordan N, Cook D. Acetaminophen II. A comparison of the physiological availabilities of different commercial dosage forms. Can J Pharm Sci. 1971; 6:38–42.
10. Bannwarth B, Netter P, Lapicque F, Gillet P, Pere P, Boccard E, Royer RJ, Gaucher A. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol. 1992; 34:79–81.
Article
11. Xu JJ, Hendriks BS, Zhao J, de Graaf D. Multiple effects of acetaminophen and p38 inhibitors: towards pathway toxicology. FEBS Lett. 2008; 582:1276–1282.
Article
12. Patten CJ, Thomas PE, Guy RL, Lee M, Gonzalez FJ, Guengerich FP, Yang CS. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993; 6:511–518.
Article
13. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis: I. role of drug metabolism. J Pharmacol Exp Ther. 1973; 187:185–194.
14. Ekins BR, Ford DC, Thompson MI, Bridges RR, Rollins DE, Jenkins RD. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med. 1987; 5:483–487.
Article
15. Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J Med Toxicol. 2008; 4:2–6.
Article
16. Lee JY, Gil HW, Yang JO, Lee EY, Hong SY. A case of acute renal failure induced by acetaminophen intoxication. Korean J Med. 2011; 80:348–351.
17. Makin A, Williams R. The current management of paracetamol overdosage. Br J Clin Pract. 1994; 48:144–148.
18. Lee WM. Acute liver failure. Dallas: Cambridge University Press;2000.
19. Flanagan RJ, Mant TG. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Hum Toxicol. 1986; 5:179–182.
Article
20. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975; 55:871–876.
Article
22. Smilkstein MJ, Douglas DR, Daya MR. Acetaminophen poisoning and liver function. N Engl J Med. 1994; 331:1310–1311.
Article
23. Prescott LF, Illingworth RN, Critchley JA, Proudfoot AT. Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. Br Med J. 1980; 280:46–47.
Article
24. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose: 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981; 141(3 Spec No):380–385.
Article
25. Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA, Caravati EM, Wax PM, Keyes DC, Woolf AD, Scharman EJ, Booze LL, Troutman WG. American Association of Poison Control Centers. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2006; 44:1–18.
Article
26. Buckley NA, Whyte IM, O'Connell DL, Dawson AH. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol. 1999; 37:753–757.
Article
27. Daly FF, Fountain JS, Murray L, Graudins A, Buckley NA. Panel of Australian and New Zealand clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand: explanation and elaboration: a consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008; 188:296–301.
28. Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000; 7:143–147.
29. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008; 359:285–292.
Article
30. Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother. 2008; 42:766–770.
Article
31. Chae HJ, Rhee NG, Kim HJ, You JS, Chung SP, Lee HS. Oral vs. Intravenous administration of N-acetylcysteine in the acetaminophen poisoning. J Korean Soc Clin Toxicol. 2012; 10:97–102.
32. Perry HE, Shannon MW. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr. 1998; 132:149–152.
Article
33. Bebarta VS, Kao L, Froberg B, Clark RF, Lavonas E, Qi M, Delgado J, McDonagh J, Arnold T, Odujebe O, O'Malley G, Lares C, Aguilera E, Dart R, Heard K, Stanford C, Kokko J, Bogdan G, Mendoza C, Mlynarchek S, Rhyee S, Hoppe J, Haur W, Tan HH, Tran NN, Varney S, Zosel A, Buchanan J, Al-Helial M. A multicenter comparison of the safety of oral versus intravenous acetylcysteine for treatment of acetaminophen overdose. Clin Toxicol (Phila). 2010; 48:424–430.
Article
34. Zyoud SH, Awang R, Syed Sulaiman SA, Sweileh WM, Al-Jabi SW. Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose. Hum Exp Toxicol. 2010; 29:153–160.
Article
35. Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol (Phila). 2008; 46:697–702.
Article
36. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila). 2009; 47:81–88.
Article
37. Mohammed S, Jamal AZ, Robison LR. Serum sickness-like illness associated with N-acetylcysteine therapy. Ann Pharmacother. 1994; 28:285.
Article
38. Lu HC, Shih RD, Marcus S, Ruck B, Jennis T. Pseudomethemoglobinemia: a case report and review of sulfhemoglobinemia. Arch Pediatr Adolesc Med. 1998; 152:803–805.
39. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med. 1998; 31:710–715.
Article
40. Elms AR, Owen KP, Albertson TE, Sutter ME. Fatal myocardial infarction associated with intravenous N-acetylcysteine error. Int J Emerg Med. 2011; 4:54.
Article
41. Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med. 2004; 44:401–406.
Article
42. Heard K, Schaeffer TH. Massive acetylcysteine overdose associated with cerebral edema and seizures. Clin Toxicol (Phila). 2011; 49:423–425.
Article
43. Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005; 17:239–245.
Article
44. Wilkes JM, Clark LE, Herrera JL. Acetaminophen overdose in pregnancy. South Med J. 2005; 98:1118–1122.
Article